tradingkey.logo

Akoya Biosciences Inc

AKYA
View Detailed Chart

1.290USD

-0.070-5.15%
Market hours ETQuotes delayed by 15 min
64.29MMarket Cap
LossP/E TTM

Akoya Biosciences Inc

1.290

-0.070-5.15%
Intraday
1m
30m
1h
D
W
M
D

Today

-5.15%

5 Days

+Infinity%

1 Month

-5.15%

6 Months

-52.92%

Year to Date

-43.67%

1 Year

-41.89%

View Detailed Chart

Agency Rating

No Data

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

1m
15m
30m
1h
D
W
M
1m
15m
30m
D
Neutral
Sell(5)
Neutral(1)
Buy(4)
Indicators
Sell(3)
Neutral(1)
Buy(0)
Indicators
Value
Direction
MACD(12,26,9)
-0.162
Neutral
RSI(14)
16.225
Oversold
STOCH(KDJ)(9,3,3)
23.916
Sell
ATR(14)
0.196
High Vlolatility
CCI(14)
-466.667
Oversold
Williams %R
100.000
Oversold
TRIX(12,20)
0.018
Sell
StochRSI(14)
0.000
Sell
Moving Average
Sell(2)
Neutral(0)
Buy(4)
Indicators
Value
Direction
MA5
1.064
Buy
MA10
1.172
Buy
MA20
1.218
Buy
MA50
1.191
Buy
MA100
1.366
Sell
MA200
2.030
Sell

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

Akoya Biosciences, Inc. is a life sciences technology company delivering spatial biology solutions focused on transforming discovery, clinical research, and diagnostics. It offers single-cell imaging solutions that allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and response to therapy. It offers a full continuum of spatial phenotyping solutions to serve the diverse needs of researchers across discovery, translational and clinical research: PhenoCode Panels and PhenoCycler, PhenoImager Fusion and PhenoImager HT Instruments. Its PhenoCycler platform provides ultra-high parameter biomarker discovery, with the ability to analyze high-plex single-cell resolution across the entire tissue sample. Its PhenoImager platform enables researchers to visualize, analyze, quantify and phenotype cells in situ, in fresh frozen or formalin-fixed paraffin-embedded (FFPE) tissue sections, and tissue microarrays (TMAs).
Ticker SymbolAKYA
CompanyAkoya Biosciences Inc
CEOMr. Brian Mckelligon
Websitehttps://www.akoyabio.com/
KeyAI